TABLE 1 Antibodies Used in this Study
Antibody | Source | Dilution | Pretreatment |
|---|---|---|---|
CD21 | DAKO | 1:50 | TP |
CD23 | The Binding Site | 1:50 | PC |
CD35 | DAKO | 1:20 | TP |
CD3 | DAKO | 1:800 | TP |
CD20 | DAKO | 1:1600 | PC |
CD4 | Novocastra | 1:10 | PC |
CD8 | DAKO | 1:100 | PC |
HHF-35 | DAKO | 1:400 | TP |
κ light chain | DAKO | 1:1000 | TP |
λ light chain | DAKO | 1:1000 | TP |